Header image

Impact Factor Journals
Innate Immune Response in Hypertension.
Current Pharmaceutical Design.
2023,
28(36),
2984-2990,
ISSN: 1381-6128,
PMID: 36154596,
Mixture Effects of Tryptophan Intestinal Microbial Metabolites on Aryl Hydrocarbon Receptor Activity.
International Journal of Molecular Sciences.
2022,
23(18),
10825,
ISSN: 1422-0067,
PMID: 36142735,
European Health Data Space-An Opportunity Now to Grasp the Future of Data-Driven Healthcare.
Healthcare.
2022,
10(9),
1629,
ISSN: 2227-9032,
PMID: 36141241,
Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors.
Archiv der Pharmazie.
2022,
355(12),
e2200419,
ISSN: 0365-6233,
PMID: 36109178,
Impact of Tumour Epstein-Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL.
Cancers.
2022,
14(17),
4297,
ISSN: 2072-6694,
PMID: 36077832,
Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells.
Cancers.
2022,
14(17),
4245,
ISSN: 2072-6694,
PMID: 36077780,
The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression.
Molecular Medicine Reports.
2022,
26(4),
321,
ISSN: 1791-2997,
PMID: 36043519,
The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature.
Current Oncology.
2022,
29(8),
5475-5488,
ISSN: 1198-0052,
PMID: 36005171,
Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana.
Parasitology International.
2022,
91,
102647,
ISSN: 1383-5769,
PMID: 35985636,